Neurology
Found 115 results
Filters: Keyword is Adult  [Clear All Filters]
2018
Chiang GC, Hu J, Morris E, Wang Y, Gauthier SA.  2018.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.. AJNR Am J Neuroradiol. 39(3):467-472.
Pillai RLI, Malhotra A, Rupert DD, Weschler B, Williams JC, Zhang M, Yang J, J Mann J, Oquendo MA, Parsey RV et al..  2018.  Relations between cortical thickness, serotonin 1A receptor binding, and structural connectivity: A multimodal imaging study.. Hum Brain Mapp. 39(2):1043-1055.
2017
Parikh NS, Schweitzer AD, Young RJ, Giambrone AE, Lyo J, Karimi S, Knobel A, Gupta A, Navi BB.  2017.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.. J Neurol Sci. 380:11-15.
Seifan A, Ganzer CA, Vermeylen F, Parry S, Zhu J, Lyons A, Isaacson R, Kim S.  2017.  Development and validation of the Alzheimer's prevention beliefs measure in a multi-ethnic cohort-a behavioral theory approach.. J Public Health (Oxf). 39(4):863-873.
Al-Kawaz M, Monohan E, Morris E, Perumal JS, Nealon N, Vartanian T, Gauthier SA.  2017.  Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans.. J Neuroimaging. 27(3):333-338.
Parikh NS, Merkler AE, Schneider Y, Navi BB, Kamel H.  2017.  Discharge Disposition After Stroke in Patients With Liver Disease.. Stroke. 48(2):476-478.
Schweitzer AD, Parikh NS, Askin G, Nemade A, Lyo J, Karimi S, Knobel A, Navi BB, Young RJ, Gupta A.  2017.  Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome.. Neuroradiology. 59(4):379-386.
Eskreis-Winkler S, Zhou D, Liu T, Gupta A, Gauthier SA, Wang Y, Spincemaille P.  2017.  On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping.. Magn Reson Imaging. 35:154-159.
Kappos L, Havrdova E, Giovannoni G, Khatri BO, Gauthier SA, Greenberg SJ, You X, Wang P, Giannattasio G.  2017.  No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.. Mult Scler. 23(13):1736-1747.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung H-P, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K et al..  2017.  Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.. N Engl J Med. 376(3):221-234.
Murthy SB, Merkler AE, Omran SSalehi, Gialdini G, Gusdon A, Hartley B, Roh D, Mangat HS, Iadecola C, Navi BB et al..  2017.  Outcomes after intracerebral hemorrhage from arteriovenous malformations.. Neurology. 88(20):1882-1888.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.. PLoS One. 12(10):e0185926.
Chen W, Zhang Y, Mu K, Pan C, Gauthier SA, Zhu W, Wang Y.  2017.  Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.. AJR Am J Roentgenol. 209(4):889-894.
Nguyen TD, Spincemaille P, Gauthier SA, Wang Y.  2017.  Rapid whole brain myelin water content mapping without an external water standard at 1.5T.. Magn Reson Imaging. 39:82-88.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.. Neurology. 89(13):1382-1390.
Mercuri MA, White H, Oliveira C.  2017.  Vision Loss and Symmetric Basal Ganglia Lesions in Leber Hereditary Optic Neuropathy.. J Neuroophthalmol. 37(4):411-413.
2016
Parikh NS, Navi BB, Kumar S, Kamel H.  2016.  Association between Liver Disease and Intracranial Hemorrhage.. J Stroke Cerebrovasc Dis. 25(3):543-8.
Parikh NS, Khazanova D, Moya A, Kaunzner UW, Allen BB, Navi BB.  2016.  Clinical Reasoning: An unusual case of blurry vision in a young woman after ovarian induction.. Neurology. 87(5):e49-53.
Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R et al..  2016.  Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.. Contemp Clin Trials. 50:166-77.
Ebben MR, Krieger AC.  2016.  Diagnostic accuracy of a mathematical model to predict apnea-hypopnea index using nighttime pulse oximetry.. J Biomed Opt. 21(3):35006.
Nguyen TD, Deh K, Monohan E, Pandya S, Spincemaille P, Raj A, Wang Y, Gauthier SA.  2016.  Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3T.. Magn Reson Med. 76(2):456-65.
Chiang GC, Pinto S, Comunale JP, Gauthier SA.  2016.  Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.. J Neuroimaging. 26(3):289-95.
Merkler AE, Parikh NS, Chaudhry S, Chait A, Allen NC, Navi BB, Kamel H.  2016.  Hospital revisit rate after a diagnosis of conversion disorder.. J Neurol Neurosurg Psychiatry. 87(4):363-6.
Zhang Y, Gauthier SA, Gupta A, Comunale J, Chiang GChia-Yi, Zhou D, Chen W, Giambrone AE, Zhu W, Wang Y.  2016.  Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).. J Magn Reson Imaging. 44(2):426-32.